Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Proactively manage your pharmacy inventory
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Anticipate generic drug launch
|Title:||Systematic evolution of ligands by exponential enrichment: chemi-selex|
|Abstract:||This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.|
|Inventor(s):||Gold; Larry (Boulder, CO), Eaton; Bruce (Boulder, CO), Smith; Drew (Boulder, CO), Wecker; Matthew (Boulder, CO), Jensen; Kirk (Boulder, CO)|
|Assignee:||NeXstar Pharmaceuticals, Inc. (Boulder, CO)|
|Filing Date:||Jun 05, 1995|
|Claims:||1. A method for identifying nucleic acids having a facilitating activity from a candidate mixture comprised of nucleic acids wherein each nucleic acid has at least one nucleic acid region and at least one chemically reactive functional unit which binds covalently with a target, said method comprising: |
a) contacting the candidate mixture with said target, wherein nucleic acids having a facilitating activity, as indicated by a covalent bond being formed between said target and said chemically reactive functional unit of said nucleic acid, may be partitioned from the remainder of the candidate mixture; and
b) partitioning the nucleic acids having a facilitating activity from the remainder of the candidate mixture, whereby nucleic acids having a facilitating activity are identified.
2. The method of claim 1 wherein after step b), the nucleic acids having a facilitating activity are amplified and steps a) and b) are repeated.
3. The method of claim 1 wherein said chemically reactive functional unit is selected from the group consisting of photoreactive groups, active site directed compounds and peptides.
4. The method of claim 1 wherein the target is modified to include a chemical moiety that reacts with the chemically reactive functional unit of the nucleic acid.
5. The method of claim 1 wherein said nucleic acid comprises a fixed region and a randomized region.
6. The method of claim 5 wherein said at least one chemically reactive functional unit is attached to an oligonucleotide hybridized to said fixed region.